New Delhi [India], July 29: Steris Healthcare, a Mumbai-headquartered pharmaceutical leader with operations in Navi Mumbai, has announced its strategic expansion into Tamil Nadu with the establishment of a state-of-the-art distribution center. This expansion follows the company’s successful entry into Kerala and reinforces its commitment to creating a robust pan-India healthcare network.
Building on its recent achievement of crossing the ₹100 crore annual sales milestone, Steris Healthcare is now set to tap into Tamil Nadu’s substantial healthcare market, one of India’s most developed and demanding pharmaceutical landscapes. The new distribution center will serve as a regional hub, ensuring seamless supply chain operations and faster delivery of medicines and healthcare products to hospitals, clinics, pharmacies, and patients across Tamil Nadu.
Mr. Jeevan Kasara, Director & CEO of Steris Healthcare, commented on the expansion, “Tamil Nadu represents a cornerstone market for pharmaceutical companies in India, with its advanced healthcare infrastructure and high awareness levels among patients and healthcare professionals. Our new distribution center will enable us to serve this sophisticated market with the speed and efficiency it demands. This expansion is integral to our vision of becoming a truly national healthcare solutions provider.”
Ms. Renuka Kasara, Director of Steris Healthcare, emphasized the strategic importance of the move, stating, “Tamil Nadu’s healthcare sector is characterized by its progressive approach and strong medical community. By establishing our presence in the state, we’re positioning ourselves to support Tamil Nadu’s healthcare ecosystem while ensuring that our innovative, affordable products reach every corner of the state. This aligns perfectly with our mission to democratize access to quality healthcare.”
The distribution center will feature advanced warehousing capabilities, temperature-controlled storage facilities, and cutting-edge logistics management systems to handle the diverse pharmaceutical requirements of Tamil Nadu’s healthcare sector. The facility is expected to create substantial employment opportunities in the region while fostering stronger partnerships with local healthcare providers, distributors, and retail pharmacies.
Tamil Nadu’s robust pharmaceutical manufacturing base, combined with its well-established healthcare delivery system, makes it an ideal location for Steris Healthcare’s expansion strategy. The state’s focus on healthcare innovation and its network of medical institutions provide a conducive environment for the company’s growth objectives.
With this expansion, Steris Healthcare continues to demonstrate its commitment to innovation, affordability, and customer-centric growth. The company’s diverse portfolio, spanning critical therapeutic segments, has earned the trust of healthcare professionals and patients across its operational markets.
The Tamil Nadu expansion marks another milestone in Steris Healthcare’s journey toward establishing a comprehensive national presence, following its successful operations in Maharashtra and recent expansion into Kerala. The company remains focused on delivering cutting-edge, affordable healthcare solutions that improve patient outcomes while supporting local healthcare ecosystems.
About Steris Healthcare
Steris Healthcare is a Mumbai-headquartered pharmaceutical company with operations in Navi Mumbai, dedicated to providing innovative and affordable healthcare solutions. With a focus on quality, accessibility, and customer satisfaction, the company has established itself as a trusted partner in India’s healthcare sector. Having crossed the ₹100 crore annual sales milestone, Steris Healthcare continues to expand its national footprint while maintaining its commitment to improving patient outcomes across the country.
If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.
